Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

ACE Inhibition and Cardiac Allograft Vasculopathy.

Next Previous
Trial Profile

ACE Inhibition and Cardiac Allograft Vasculopathy.

Status: Recruiting
Phase of Trial: Phase III

Latest Information Update: 08 Nov 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Ramipril (Primary)
  • Indications Cardiovascular disorders; Heart transplant rejection; Vascular disorders
  • Focus Adverse reactions; Therapeutic Use

Most Recent Events

  • 09 Jan 2020 Results of long-term clinical follow up on subjects included in the ACEI after HT study published in the American Heart Journal
  • 27 Mar 2013 Planned end date changed from 1 Apr 2014 to 1 Apr 2015 as reported by ClinicalTrials.gov.
  • 06 Mar 2010 New trial record

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top